- call +1-201-465-4211
- email sales@mrinsights.biz
The key elements of an amino acid are carbon (C), hydrogen (H), oxygen (O), and nitrogen (N), although other elements are found in the side chains of certain amino acids. Some amino acids derivatives are used in pharmaceutical industry. They include 5-HTP (5-hydroxytryptophan) used for experimental treatment of depression, L-DOPA (L-dihydroxyphenylalanine) for Parkinson's treatment, and eflornithine drug that inhibits ornithine decarboxylase and used in the treatment of sleeping sickness. A metabolic disorder can happen when abnormal chemical reactions in the body alter the normal metabolic process. It can also be defined as inherited single gene anomaly, most of which are autosomal recessive.
Scope of the Report:
This report focuses on the Amino Acid Metabolism Disorders Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
In the global market, North America is projected to retain a leading position in the market by the end of 2025 reaching a valuation of over US$359 Mn. It is expected to be closely followed by Europe.
The worldwide market for Amino Acid Metabolism Disorders Treatment is expected to grow at a CAGR of roughly 5.1% over the next five years, will reach 1020 million US$ in 2023, from 750 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
GlaxoSmithKline
Pfizer
AMINO
Merck
Recordati
Koninklijke
Sanofi
Shine Star (Hubei) Biological Engineering
Kyowa Hakko Kirin
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Arginine
Folic Acid
Vitamin B6 & B12
Thiamine
Vitamin D
Betaine
Carglumic Acid
Saproterin Dihydrochloride
Others
Market Segment by Applications, can be divided into
Phenylketonuria
Maple Syrup Urine Disease
Argininosuccinic Acidemia
Citrullinemia
Homocystinuria
There are 15 Chapters to deeply display the global Amino Acid Metabolism Disorders Treatment market.
Chapter 1, to describe Amino Acid Metabolism Disorders Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Amino Acid Metabolism Disorders Treatment, with sales, revenue, and price of Amino Acid Metabolism Disorders Treatment, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Amino Acid Metabolism Disorders Treatment, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Amino Acid Metabolism Disorders Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Amino Acid Metabolism Disorders Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Amino Acid Metabolism Disorders Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Arginine
1.2.2 Folic Acid
1.2.3 Vitamin B6 & B12
1.2.4 Thiamine
1.2.5 Vitamin D
1.2.6 Betaine
1.2.7 Carglumic Acid
1.2.8 Saproterin Dihydrochloride
1.2.9 Others
1.3 Market Analysis by Applications
1.3.1 Phenylketonuria
1.3.2 Maple Syrup Urine Disease
1.3.3 Argininosuccinic Acidemia
1.3.4 Citrullinemia
1.3.5 Homocystinuria
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 Business Overview
2.1.2 Amino Acid Metabolism Disorders Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GlaxoSmithKline Amino Acid Metabolism Disorders Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Amino Acid Metabolism Disorders Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Amino Acid Metabolism Disorders Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 AMINO
2.3.1 Business Overview
2.3.2 Amino Acid Metabolism Disorders Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AMINO Amino Acid Metabolism Disorders Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
2.4.1 Business Overview
2.4.2 Amino Acid Metabolism Disorders Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Amino Acid Metabolism Disorders Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Recordati
2.5.1 Business Overview
2.5.2 Amino Acid Metabolism Disorders Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Recordati Amino Acid Metabolism Disorders Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Koninklijke
2.6.1 Business Overview
2.6.2 Amino Acid Metabolism Disorders Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Koninklijke Amino Acid Metabolism Disorders Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Sanofi
2.7.1 Business Overview
2.7.2 Amino Acid Metabolism Disorders Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sanofi Amino Acid Metabolism Disorders Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Shine Star (Hubei) Biological Engineering
2.8.1 Business Overview
2.8.2 Amino Acid Metabolism Disorders Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorders Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Kyowa Hakko Kirin
2.9.1 Business Overview
2.9.2 Amino Acid Metabolism Disorders Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Kyowa Hakko Kirin Amino Acid Metabolism Disorders Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Amino Acid Metabolism Disorders Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Amino Acid Metabolism Disorders Treatment Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Amino Acid Metabolism Disorders Treatment Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Amino Acid Metabolism Disorders Treatment Manufacturer Market Share in 2017
3.3.2 Top 6 Amino Acid Metabolism Disorders Treatment Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Amino Acid Metabolism Disorders Treatment Market Analysis by Regions
4.1 Global Amino Acid Metabolism Disorders Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Amino Acid Metabolism Disorders Treatment Sales and Market Share by Regions (2013-2018)
4.1.2 Global Amino Acid Metabolism Disorders Treatment Revenue and Market Share by Regions (2013-2018)
4.2 North America Amino Acid Metabolism Disorders Treatment Sales and Growth Rate (2013-2018)
4.3 Europe Amino Acid Metabolism Disorders Treatment Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Amino Acid Metabolism Disorders Treatment Sales and Growth Rate (2013-2018)
4.5 South America Amino Acid Metabolism Disorders Treatment Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Amino Acid Metabolism Disorders Treatment Sales and Growth Rate (2013-2018)
5 North America Amino Acid Metabolism Disorders Treatment by Countries
5.1 North America Amino Acid Metabolism Disorders Treatment Sales, Revenue and Market Share by Countries
5.1.1 North America Amino Acid Metabolism Disorders Treatment Sales and Market Share by Countries (2013-2018)
5.1.2 North America Amino Acid Metabolism Disorders Treatment Revenue and Market Share by Countries (2013-2018)
5.2 United States Amino Acid Metabolism Disorders Treatment Sales and Growth Rate (2013-2018)
5.3 Canada Amino Acid Metabolism Disorders Treatment Sales and Growth Rate (2013-2018)
5.4 Mexico Amino Acid Metabolism Disorders Treatment Sales and Growth Rate (2013-2018)
6 Europe Amino Acid Metabolism Disorders Treatment by Countries
6.1 Europe Amino Acid Metabolism Disorders Treatment Sales, Revenue and Market Share by Countries
6.1.1 Europe Amino Acid Metabolism Disorders Treatment Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Amino Acid Metabolism Disorders Treatment Revenue and Market Share by Countries (2013-2018)
6.2 Germany Amino Acid Metabolism Disorders Treatment Sales and Growth Rate (2013-2018)
6.3 UK Amino Acid Metabolism Disorders Treatment Sales and Growth Rate (2013-2018)
6.4 France Amino Acid Metabolism Disorders Treatment Sales and Growth Rate (2013-2018)
6.5 Russia Amino Acid Metabolism Disorders Treatment Sales and Growth Rate (2013-2018)
6.6 Italy Amino Acid Metabolism Disorders Treatment Sales and Growth Rate (2013-2018)
7 Asia-Pacific Amino Acid Metabolism Disorders Treatment by Countries
7.1 Asia-Pacific Amino Acid Metabolism Disorders Treatment Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Amino Acid Metabolism Disorders Treatment Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Amino Acid Metabolism Disorders Treatment Revenue and Market Share by Countries (2013-2018)
7.2 China Amino Acid Metabolism Disorders Treatment Sales and Growth Rate (2013-2018)
7.3 Japan Amino Acid Metabolism Disorders Treatment Sales and Growth Rate (2013-2018)
7.4 Korea Amino Acid Metabolism Disorders Treatment Sales and Growth Rate (2013-2018)
7.5 India Amino Acid Metabolism Disorders Treatment Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Amino Acid Metabolism Disorders Treatment Sales and Growth Rate (2013-2018)
8 South America Amino Acid Metabolism Disorders Treatment by Countries
8.1 South America Amino Acid Metabolism Disorders Treatment Sales, Revenue and Market Share by Countries
8.1.1 South America Amino Acid Metabolism Disorders Treatment Sales and Market Share by Countries (2013-2018)
8.1.2 South America Amino Acid Metabolism Disorders Treatment Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Amino Acid Metabolism Disorders Treatment Sales and Growth Rate (2013-2018)
8.3 Argentina Amino Acid Metabolism Disorders Treatment Sales and Growth Rate (2013-2018)
8.4 Colombia Amino Acid Metabolism Disorders Treatment Sales and Growth Rate (2013-2018)
9 Middle East and Africa Amino Acid Metabolism Disorders Treatment by Countries
9.1 Middle East and Africa Amino Acid Metabolism Disorders Treatment Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Amino Acid Metabolism Disorders Treatment Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Amino Acid Metabolism Disorders Treatment Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Amino Acid Metabolism Disorders Treatment Sales and Growth Rate (2013-2018)
9.3 UAE Amino Acid Metabolism Disorders Treatment Sales and Growth Rate (2013-2018)
9.4 Egypt Amino Acid Metabolism Disorders Treatment Sales and Growth Rate (2013-2018)
9.5 Nigeria Amino Acid Metabolism Disorders Treatment Sales and Growth Rate (2013-2018)
9.6 South Africa Amino Acid Metabolism Disorders Treatment Sales and Growth Rate (2013-2018)
10 Global Amino Acid Metabolism Disorders Treatment Market Segment by Type
10.1 Global Amino Acid Metabolism Disorders Treatment Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Amino Acid Metabolism Disorders Treatment Sales and Market Share by Type (2013-2018)
10.1.2 Global Amino Acid Metabolism Disorders Treatment Revenue and Market Share by Type (2013-2018)
10.2 Arginine Sales Growth and Price
10.2.1 Global Arginine Sales Growth (2013-2018)
10.2.2 Global Arginine Price (2013-2018)
10.3 Folic Acid Sales Growth and Price
10.3.1 Global Folic Acid Sales Growth (2013-2018)
10.3.2 Global Folic Acid Price (2013-2018)
10.4 Vitamin B6 & B12 Sales Growth and Price
10.4.1 Global Vitamin B6 & B12 Sales Growth (2013-2018)
10.4.2 Global Vitamin B6 & B12 Price (2013-2018)
10.5 Thiamine Sales Growth and Price
10.5.1 Global Thiamine Sales Growth (2013-2018)
10.5.2 Global Thiamine Price (2013-2018)
10.6 Vitamin D Sales Growth and Price
10.6.1 Global Vitamin D Sales Growth (2013-2018)
10.6.2 Global Vitamin D Price (2013-2018)
10.7 Betaine Sales Growth and Price
10.7.1 Global Betaine Sales Growth (2013-2018)
10.7.2 Global Betaine Price (2013-2018)
10.8 Carglumic Acid Sales Growth and Price
10.8.1 Global Carglumic Acid Sales Growth (2013-2018)
10.8.2 Global Carglumic Acid Price (2013-2018)
10.9 Saproterin Dihydrochloride Sales Growth and Price
10.9.1 Global Saproterin Dihydrochloride Sales Growth (2013-2018)
10.9.2 Global Saproterin Dihydrochloride Price (2013-2018)
10.10 Others Sales Growth and Price
10.10.1 Global Others Sales Growth (2013-2018)
10.10.2 Global Others Price (2013-2018)
11 Global Amino Acid Metabolism Disorders Treatment Market Segment by Application
11.1 Global Amino Acid Metabolism Disorders Treatment Sales Market Share by Application (2013-2018)
11.2 Phenylketonuria Sales Growth (2013-2018)
11.3 Maple Syrup Urine Disease Sales Growth (2013-2018)
11.4 Argininosuccinic Acidemia Sales Growth (2013-2018)
11.5 Citrullinemia Sales Growth (2013-2018)
11.6 Homocystinuria Sales Growth (2013-2018)
12 Amino Acid Metabolism Disorders Treatment Market Forecast (2018-2023)
12.1 Global Amino Acid Metabolism Disorders Treatment Sales, Revenue and Growth Rate (2018-2023)
12.2 Amino Acid Metabolism Disorders Treatment Market Forecast by Regions (2018-2023)
12.2.1 North America Amino Acid Metabolism Disorders Treatment Market Forecast (2018-2023)
12.2.2 Europe Amino Acid Metabolism Disorders Treatment Market Forecast (2018-2023)
12.2.3 Asia-Pacific Amino Acid Metabolism Disorders Treatment Market Forecast (2018-2023)
12.2.4 South America Amino Acid Metabolism Disorders Treatment Market Forecast (2018-2023)
12.2.5 Middle East and Africa Amino Acid Metabolism Disorders Treatment Market Forecast (2018-2023)
12.3 Amino Acid Metabolism Disorders Treatment Market Forecast by Type (2018-2023)
12.3.1 Global Amino Acid Metabolism Disorders Treatment Sales Forecast by Type (2018-2023)
12.3.2 Global Amino Acid Metabolism Disorders Treatment Market Share Forecast by Type (2018-2023)
12.4 Amino Acid Metabolism Disorders Treatment Market Forecast by Application (2018-2023)
12.4.1 Global Amino Acid Metabolism Disorders Treatment Sales Forecast by Application (2018-2023)
12.4.2 Global Amino Acid Metabolism Disorders Treatment Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Amino Acid Metabolism Disorders Treatment Picture
Table Product Specifications of Amino Acid Metabolism Disorders Treatment
Figure Global Sales Market Share of Amino
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
